Clinical trials
Chronic Limb-Threatening Ischemia trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 8 |
| 2019 | 9 |
| 2020 | 11 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 82 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 3 |
| Assiut University | 2 |
| Biotyx Medical (Shenzhen) Co., Ltd. | 2 |
| Clinical Centre of Serbia | 2 |
| Ospedale San Donato | 2 |
| Singapore General Hospital | 2 |
| Xuanwu Hospital, Beijing | 2 |
| Yonsei University | 2 |
| Ain Shams University | 1 |
| Allife Medical Science and Technology Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chronic Limb-Threatening Ischemia | 82 |
| Peripheral Arterial Disease | 26 |
| Peripheral Vascular Diseases | 10 |
| Intermittent Claudication | 8 |
| Diabetic Foot | 7 |
| Vascular Diseases | 7 |
| Diabetes Mellitus | 4 |
| Thromboangiitis Obliterans | 4 |
| Arterial Occlusive Diseases | 3 |
| Arteriosclerosis Obliterans | 2 |
Trials
Showing 26 to 50 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.